Searched for
DHIRAJLAL KOTADIA
Ashish Kacholia and Samara Capital backed Sahajanand Medical Technologies files DRHP for IPOSahajanand Medical Technologies (SMT) has filed for an IPO with SEBI to raise funds through an offer-for-sale of 27,644,231 equity shares. ...- SMT appoints Bhargav Kotadia as chief executive officerSamara Capital-backed Sahajanand Medical Technologies has named Bhargav Kotadia as CEO and Jose Calle Gordo (‘Pepe’) as chairman, effective...
- Cipla, Alkem Laboratories in final lap to buy SMTPromoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest thei...
- Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMTMorgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias...
- Five years on, Morgan Stanley PE to exit cardiac stent maker SMTExisting investor Samara Capital and the promoter, Dhirajlal Kotadia and his family, are also likely to sell an about 15-20% stake between ...
- Kotak Pre-IPO fund buys minority stake in stent maker SMTThe Rs 2,000-crore Kotak fund, an India-focused late-stage alternative investment fund (AIF), primarily focuses on investments in late-stag...
- Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuationEstablished in 1998, SMT develops and manufactures cardiac products that are sold in 75 countries. Its portfolio includes coronary stents (...
Load More